PARP-1/2 inhibitors (Eternity Bioscience)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePARP-1/2 inhibitors (Eternity Bioscience)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) Polymerase 2 inhibitorsPoly (ADP-Ribose) polymerase 1 inhibitors
TargetsPoly (ADP-Ribose) Polymerase 2Poly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesEternity Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEternity Bioscience Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A